Related Experiment Videos
[Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity]
Objective:
To study the growth inhibitory and chemo-sensitizing effects of adenovirus E1A gene on HER2/neu-overexpressing tumor cell lines.
Methods:
E1A was transfected in vitro and in vivo by adenovirus vector into HER2/neu overexpressing human mammary cancer cell lines MDA-MB-453 and SKBR3 and their growth was monitored. The chemo-sensitizing effect was examined by MTT assay.
Results:
E1A greatly inhibited growth of HER2/neu-overexpressing tumor and prolonged the survival time of tumor-bearing mice. Western blot and immunohistochemical analysis both showed suppression of p185 protein expression in E1A-transfected HER2/neu overexpressing cancer cell lines. E1A could sensitize HER2/neu-overexpressing human breast cancer cells to Taxotere by repressing HER2/neu expression.
Conclusion:
Adenovirus E1A inhibits tumor growth and sensitizes tumor cells to chemotherapeutic agent via down regulation of HER2/neu expression.
Insights
Adenovirus E1A gene effectively inhibits growth of HER2/neu-overexpressing tumors and enhances chemotherapy sensitivity. This involves downregulating HER2/neu expression, offering a potential new therapeutic strategy for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Context:
- HER2/neu overexpression is a key driver in certain aggressive breast cancers.
- Adenovirus-mediated gene delivery offers a platform for targeted cancer therapies.
Purpose:
- To investigate the therapeutic potential of the adenovirus E1A gene in HER2/neu-overexpressing breast cancer models.
- To assess the impact of E1A on tumor growth, survival, and chemosensitivity.
Summary:
- Adenovirus E1A gene transfection significantly inhibited the growth of HER2/neu-overexpressing human mammary cancer cell lines (MDA-MB-453, SKBR3) in vitro and in vivo.
- E1A expression suppressed p185 protein levels and sensitized cancer cells to Taxotere chemotherapy by downregulating HER2/neu expression.
- Tumor-bearing mice treated with E1A showed prolonged survival.
Impact:
- Adenovirus E1A demonstrates significant tumor growth inhibitory effects in HER2/neu-overexpressing cancers.
- E1A acts as a chemo-sensitizing agent, enhancing the efficacy of Taxotere by targeting HER2/neu.
- This research highlights a potential gene therapy approach for HER2/neu-positive breast cancers.